Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)
Egypt
· Delayed Price · Currency is EGP 420.96
0.00 (0.00%)
At close: Jun 25, 2025
EGX:AXPH Balance Sheet
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Cash & Equivalents | 171.4 | 150.04 | 90.51 | 153.75 | 52.12 | 166.61 | Upgrade
|
| Cash & Short-Term Investments | 171.4 | 150.04 | 90.51 | 153.75 | 52.12 | 166.61 | Upgrade
|
| Cash Growth | 21.53% | 65.77% | -41.13% | 194.98% | -68.72% | -0.00% | Upgrade
|
| Accounts Receivable | 247.95 | 62.7 | 66.91 | 113.61 | 106.2 | 113.12 | Upgrade
|
| Other Receivables | 119.66 | 87.2 | 28.14 | 22.65 | 27.34 | 11.73 | Upgrade
|
| Receivables | 410.07 | 186.19 | 144.18 | 168.13 | 166.16 | 196.13 | Upgrade
|
| Inventory | 533.67 | 522.51 | 345.41 | 271.51 | 307.64 | 270.69 | Upgrade
|
| Prepaid Expenses | 0.19 | 0.19 | 0.27 | 0.36 | 0.05 | 0.19 | Upgrade
|
| Restricted Cash | - | - | - | 0 | 0.86 | 1.03 | Upgrade
|
| Other Current Assets | - | - | -0 | 0 | -0 | - | Upgrade
|
| Total Current Assets | 1,115 | 858.93 | 580.36 | 593.76 | 526.82 | 634.65 | Upgrade
|
| Property, Plant & Equipment | 371.77 | 379.71 | 340.24 | 279.06 | 264.29 | 165.96 | Upgrade
|
| Long-Term Investments | 2.39 | 2.39 | 2.39 | 2.39 | 2.39 | 2.39 | Upgrade
|
| Other Long-Term Assets | - | - | -0 | - | - | -0 | Upgrade
|
| Total Assets | 1,489 | 1,241 | 922.99 | 875.21 | 793.49 | 803 | Upgrade
|
| Accounts Payable | 328.45 | 277.85 | 139.28 | 160.86 | 92.14 | 102.61 | Upgrade
|
| Accrued Expenses | 3.6 | 5.17 | 4.16 | 4.32 | 6.45 | 5.13 | Upgrade
|
| Short-Term Debt | 1.55 | 0.81 | 12.03 | 9.11 | 1.77 | 7.84 | Upgrade
|
| Current Unearned Revenue | 0.24 | 0.24 | 1.25 | - | - | - | Upgrade
|
| Other Current Liabilities | 207.4 | 152.4 | 91.7 | 78.13 | 99.48 | 106.87 | Upgrade
|
| Total Current Liabilities | 541.24 | 436.47 | 248.42 | 252.43 | 199.83 | 222.44 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 9.57 | 9.57 | 14.44 | 10.18 | 7.46 | 8.61 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | -0 | Upgrade
|
| Total Liabilities | 550.81 | 446.04 | 262.85 | 262.6 | 207.29 | 231.05 | Upgrade
|
| Common Stock | 50 | 50 | 50 | 50 | 50 | 50 | Upgrade
|
| Retained Earnings | 819.22 | 738.24 | 604.42 | 494.73 | 530.88 | 517.13 | Upgrade
|
| Comprehensive Income & Other | 69.46 | 6.74 | 5.72 | 67.87 | 5.32 | 4.82 | Upgrade
|
| Shareholders' Equity | 938.68 | 794.98 | 660.14 | 612.6 | 586.2 | 571.95 | Upgrade
|
| Total Liabilities & Equity | 1,489 | 1,241 | 922.99 | 875.21 | 793.49 | 803 | Upgrade
|
| Total Debt | 1.55 | 0.81 | 12.03 | 9.11 | 1.77 | 7.84 | Upgrade
|
| Net Cash (Debt) | 169.86 | 149.22 | 78.48 | 144.63 | 50.35 | 158.77 | Upgrade
|
| Net Cash Growth | 23.51% | 90.14% | -45.74% | 187.27% | -68.29% | -4.71% | Upgrade
|
| Net Cash Per Share | - | 29.84 | 15.70 | 28.93 | 10.07 | 26.88 | Upgrade
|
| Filing Date Shares Outstanding | - | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Total Common Shares Outstanding | - | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Working Capital | 574.1 | 422.46 | 331.94 | 341.33 | 326.99 | 412.21 | Upgrade
|
| Book Value Per Share | - | 159.00 | 132.03 | 122.52 | 117.24 | 114.39 | Upgrade
|
| Tangible Book Value | 938.68 | 794.98 | 660.14 | 612.6 | 586.2 | 571.95 | Upgrade
|
| Tangible Book Value Per Share | - | 159.00 | 132.03 | 122.52 | 117.24 | 114.39 | Upgrade
|
| Land | - | 0.08 | - | - | 0.08 | 0.08 | Upgrade
|
| Buildings | - | 115.08 | - | - | 38.75 | 42.37 | Upgrade
|
| Machinery | - | 420.3 | - | - | 306.41 | 266.23 | Upgrade
|
| Construction In Progress | - | 153.05 | - | - | 134.55 | 62.82 | Upgrade
|
Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.